Researcher
An Coosemans
- Disciplines:Cancer therapy, Cancer biology, Neurosurgery
Affiliations
- Laboratory for Tumor Immunology and Immunotherapy (Division)
Responsible
From1 Oct 2019 → Today - Laboratory for Tumor Immunology and Immunotherapy (Division)
Member
From1 Sep 2016 → Today - Gynaecological Oncology (Division)
Member
From1 Oct 2013 → 31 Aug 2016 - Allergy and Clinical Immunology Research Group (Division)
Member
From1 Oct 2012 → 30 Sep 2013
Projects
1 - 10 of 18
- Development of tumor-derived dendritic cell therapies to prevent ovarian cancer metastasisFrom13 Nov 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- How to deal with recurrent ovarian cancer: a new approach.From1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Developing combinatorial immunotherapy for glioblastomaFrom7 Nov 2022 → TodayFunding: Foundations, funds and other with scientific goal
- Next-generation, multi-technology immune-monitoring and easy-access spectral flow cytometryFrom1 May 2022 → TodayFunding: FWO Medium Size Research Infrastructure
- DIPITO: valorisation of deep immune profiling and novel immunotherapeutics for oncology.From1 Oct 2021 → TodayFunding: IOF - mandates
- Preclinical evaluation of novel radionuclide therapies in different cancer modelsFrom8 Jul 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Deciphering the dendritic cell compartment in ovarian cancer to assess their potential as tumor vaccines.From1 Jan 2021 → TodayFunding: FWO research project (including WEAVE projects)
- Spectral flowcytometry (Cytek Aurora)From1 Jan 2021 → 31 Dec 2022Funding: BOF - scientific equipment program
- Deciphering the dendritic cell compartment in ovarian cancer to assess their potential as tumor vaccinesFrom8 Oct 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Rational approach for immunotherapy in ovarian cancer.From1 Sep 2020 → TodayFunding: Foundations, funds and other with scientific goal
Publications
11 - 20 of 114
- Radiation dose-escalation and dose-fractionation modulate the immune microenvironment, cancer stem cells and vasculature in experimental high-grade gliomas(2023)
Authors: Matteo Riva, Roxanne Wouters, David Nittner, Jolien Ceusters, Edmond Sterpin, Uwe Himmelreich, Willy Gsell, Marc Van Ranst, An Coosemans
Pages: 55 - 65 - Benign descriptors and ADNEX in two-step strategy to estimate risk of malignancy in ovarian tumors: retrospective validation in IOTA5 multicenter cohort(2023)
Authors: Tom Bourne, Wouter Froyman, Ben Van Calster, Jolien Ceusters, Laure Wynants, An Coosemans, Ignace Vergote, Dirk Timmerman
Pages: 231 - 242 - Trial watch: Dendritic cell (DC)-based immunotherapy for cancer(2022)
Authors: Jenny Sprooten, Stefan Naulaerts, Benoit Beuselinck, An Coosemans, Lisa Kinget, Sandra Tuyaerts, Steven De Vleeschouwer, Abhishek Garg
- Peripheral gene signatures reveal distinct cancer patient immunotypes with therapeutic implications for autologous DC-based vaccines(2022)
Authors: An Coosemans, Ignace Vergote, Abhishek Garg
- Do autoimmune diseases influence the onset and progression of ovarian cancer? A systematic review and meta-analysis(2022)
Authors: Roxanne Wouters, Ann Vankerckhoven, Jolien Ceusters, An Coosemans
Pages: 1583 - 1591 - Unravelling The Tumour Immune-Biology Of Ovarian Cancer(2022)
Authors: Ann Vankerckhoven, An Coosemans, Stefaan Soenen
- Pan-Cancer Detection and Typing by Mining Patterns in Large Genome-Wide Cell-Free DNA Sequencing Datasets(2022)
Authors: Huiwen Che, Tatjana Jatsenko, Liesbeth Lenaerts, Nathalie Brison, Kris Van Den Bogaert, Ruben Heremans, Agnieszka Wozniak, Christophe Dooms, Els Wauters, Sigrid Hatse, et al.
Pages: 1164 - 1176 - Dendritic Cell Vaccines: A Promising Approach in the Fight against Ovarian Cancer(2022)
Authors: Aarushi Audhut Caro, An Coosemans
- An Autologous Dendritic Cell Vaccine Promotes Anticancer Immunity in Patients with Ovarian Cancer with Low Mutational Burden and Cold Tumors(2022)
Authors: An Coosemans, Ignace Vergote
Pages: 3053 - 3065 - Liquid Biopsy in Glioblastoma(2022)
Authors: Matteo Riva, An Coosemans
Patents
1 - 4 of 4
Linked dataset
1 - 1 of 1